Primary CNS lymphoma at first relapse/progression: characteristics, management, and outcome of 256 patients from the French LOC network-Reference-Cited by-同舟云学术

Primary CNS lymphoma at first relapse/progression: characteristics, management, and outcome of 256 patients from the French LOC network

Published:2016-03-06 Issue:9 Volume:18 Page:1297-1303
ISSN:1522-8517
Container-title:Neuro-Oncology
language:en
Short-container-title:NEUONC

Author:

Langner-Lemercier Sophie,Houillier Caroline,Soussain Carole,Ghesquières Hervé,Chinot Olivier,Taillandier Luc,Soubeyran Pierre,Lamy Thierry,Morschhauser Franck,Benouaich-Amiel Alexandra,Ahle Guido,Moles-Moreau Marie-Pierre,Moluçon-Chabrot Cécile,Bourquard Pascal,Damaj Ghandi,Jardin Fabrice,Larrieu Delphine,Gyan Emmanuel,Gressin Remy,Jaccard Arnaud,Choquet Sylvain,Brion Annie,Casasnovas Olivier,Colin Philippe,Reman Oumedaly,Tempescul Adrian,Marolleau Jean-Pierre,Fabbro Michel,Naudet Florian,Hoang-Xuan Khê,Houot Roch

Funder

Institut National du Cancer (INCa)

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Clinical Neurology,Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/18/9/1297/17431034/now033.pdf

Reference25 articles.

1. French Brain Tumor DataBase: 5-Year Histological Results on 25 756 Cases

2. Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology

3. Relapse of primary central nervous system lymphoma: clinical features, outcome and prognostic factors

4. Primary central nervous system lymphoma: The role of consolidation treatment after a complete response to high-dose methotrexate-based chemotherapy

5. Role of chemotherapy additional to high-dose methotrexate for primary central nervous system lymphoma (PCNSL);Bergner;Cochrane Database Syst Rev,2012

Cited by 133 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case report: Successful treatment of a patient with relapsed/refractory primary central nervous system lymphoma with thiotepa-based induction, autologous stem cell transplantation and maintenance;Frontiers in Oncology;2024-01-29

2. Efficacy of BTK inhibitor administered for central high-risk systemic diffuse large B cell lymphoma and primary central nervous system lymphoma: A single-center retrospective study;2024-01-03

3. Clinical outcomes of newly diagnosed primary central nervous system lymphoma treated with zanubrutinib-based combination therapy;World Journal of Clinical Oncology;2023-12-24

4. Epileptic seizures in patients with primary central nervous system lymphoma: A systematic review;Revue Neurologique;2023-12

5. Central Nervous System Lymphoma;CONTINUUM: Lifelong Learning in Neurology;2023-12